IRIS
CELESIA, BENEDETTO MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.990
AS - Asia 3.037
EU - Europa 2.807
SA - Sud America 504
AF - Africa 411
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.819
SG - Singapore 1.468
RU - Federazione Russa 1.171
CN - Cina 731
IT - Italia 548
BR - Brasile 411
VN - Vietnam 305
IE - Irlanda 263
CI - Costa d'Avorio 192
DE - Germania 150
FR - Francia 144
KR - Corea 143
UA - Ucraina 140
IN - India 117
NG - Nigeria 111
CA - Canada 108
FI - Finlandia 94
BD - Bangladesh 87
GB - Regno Unito 73
SE - Svezia 45
SN - Senegal 43
HK - Hong Kong 39
NL - Olanda 38
MX - Messico 37
PL - Polonia 37
AR - Argentina 28
ES - Italia 23
ZA - Sudafrica 23
ID - Indonesia 19
IQ - Iraq 19
CO - Colombia 18
PK - Pakistan 17
JP - Giappone 15
BE - Belgio 14
EC - Ecuador 14
AT - Austria 12
TR - Turchia 11
VE - Venezuela 10
CH - Svizzera 9
CL - Cile 9
KE - Kenya 9
LB - Libano 9
BJ - Benin 8
GR - Grecia 8
PY - Paraguay 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
IR - Iran 7
JM - Giamaica 7
SA - Arabia Saudita 7
TN - Tunisia 7
AU - Australia 6
JO - Giordania 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
EG - Egitto 4
LT - Lituania 4
LV - Lettonia 4
NP - Nepal 4
DK - Danimarca 3
HR - Croazia 3
HU - Ungheria 3
MY - Malesia 3
OM - Oman 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
PH - Filippine 2
PR - Porto Rico 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
Totale 11.749
Salva come PNG Salva come JPEG
Città #
Dallas 909
Singapore 884
Santa Clara 650
Moscow 523
San Jose 380
Chandler 379
Ashburn 283
Dublin 261
Los Angeles 199
Abidjan 192
Beijing 177
Chicago 161
Jacksonville 151
Seoul 143
Hefei 138
Lauterbourg 124
Boardman 119
New York 115
Catania 107
Ho Chi Minh City 97
Munich 89
Abuja 84
Buffalo 64
Cambridge 64
Hanoi 64
Lawrence 64
Council Bluffs 61
Civitanova Marche 57
São Paulo 56
Andover 55
Helsinki 50
Toronto 50
Kochi 48
Dakar 42
Hong Kong 36
Rome 36
Des Moines 35
Nanjing 34
Orem 33
Warsaw 33
Lappeenranta 30
Montreal 30
Houston 28
Denver 25
Nanchang 25
Brooklyn 24
Wilmington 22
Atlanta 20
The Dalles 20
Chennai 19
Lagos 19
Milan 19
Amsterdam 18
Columbus 18
London 18
Phoenix 18
Boston 17
Mexico City 17
Palermo 16
Stockholm 16
Da Nang 15
Johannesburg 15
Poplar 15
San Mateo 15
Modica 14
Parma 14
Tokyo 14
Brussels 13
Philadelphia 13
Rende 13
Rio de Janeiro 13
Changsha 12
Grafing 12
Mumbai 12
Shenyang 12
Bremen 11
Dong Ket 11
Jiaxing 11
Milazzo 11
Tremestieri Etneo 11
Hebei 10
Ottawa 10
Seattle 10
Charlotte 9
Nairobi 9
New Delhi 9
Saint Petersburg 9
Cotonou 8
Madrid 8
Manchester 8
Miami 8
Port Harcourt 8
San Francisco 8
Shanghai 8
Tashkent 8
Tianjin 8
Turku 8
Bari 7
Biên Hòa 7
Brasília 7
Totale 7.890
Salva come PNG Salva come JPEG
Nome #
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 336
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 166
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 161
[In Process Citation] 160
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 156
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 155
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 145
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 141
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 133
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 131
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 129
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 125
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 123
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 118
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 118
Anxiety disorders and adherence to HAART 116
Analysis of impediments to the maintenance in care of people with HIV in Italy 116
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 116
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 116
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 116
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 116
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 115
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 115
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 113
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 109
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 108
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 108
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 107
Hepatic echinococcosis: clinical and therapeutic aspects 107
High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review 106
Factors predicting tuberculosis reactivation in HIV-infected patients [PARAMETRI PREDITTIVI DI RIATTIVAZIONE TUBERCOLARE IN SOGGETTI CON INFEZIONE DA HIV] 106
Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review 105
Successful extracorporeal membrane oxygenation treatment in an acquired immune deficiency syndrome (AIDS) patient with acute respiratory distress syndrome (ARDS) complicating pneumocystis jirovecii pneumonia: A challenging case 104
Kidney disease in HIV-infected patients 103
Predictive criteria of sustained virological response (more than 60 months) to Nevirapine-based antiretroviral treatment 102
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 101
Trimethoprim-sulfamthoxazole associated severe hypoglicemia: a sulfnylurea like effect 101
Editorial-Coronavirus disease 2019 and people living with HIV: Clinical considerations 100
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review 99
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy 98
Efficacy and safety of Atazanavir/Ritonavir therapy in a cohort of treatment-experienced patients 98
Possible role of low dose dexamethasone administration in listeria monocytogenes meningoencephalitis: A case series 98
Cryptococcal meningitis in an HIV-1-infected person: relapses or IRIS? Case report and review of the literature 97
Ruolo del rapporto eterosessuale nella trasmissione dell’infezione HIV in un gruppo di tossicodipendenti della Sicilia Orientale. Necessità di modificare le strategie di prevenzione? 97
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 97
Pain crisis management in a patient with sickle cell disease during SARS‑CoV‑2 infection: A case report and literature review 97
Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience 97
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature 96
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 94
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 94
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 90
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 90
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 90
Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders 90
Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study 89
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 88
Sifilide ed HIV.Presentazione di tre casi clinici 88
Serum tumor necrosis factor in acute and fulminant hepatitis B 87
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 87
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 87
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment 87
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 86
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 86
Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study 86
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 85
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 81
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily 80
Microbial translocation in chronic liver diseases 79
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 78
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey 77
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals 77
Ageing with HIV: a multidisciplinary review 77
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 76
Localizzazione osteoarticolare multipla in corso di sepsi da Staphylococcus aureus meticillino-resistente: Considerazioni clinico- terapeutiche [Multiple osteo-articular involvement due to methicillin-resistant Staphylococcus aureus septicaemia: clinical and therapeutic evaluation] 76
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 74
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 74
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: A cross-sectional study 74
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 74
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 73
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial 72
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review 71
HCV and HIV infection among intravenous drug abusers in eastern Sicily 71
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 71
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 71
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 71
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 70
Sexual dysfunction in HIV plus subjects in eastern Sicily 70
Factors associated with weight gain in people treated with dolutegravir 70
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 70
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 68
Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report 67
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 66
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment 65
Prevalenza e distribuzione dell’HHV-8 in differenti popolazioni con e senza infezione da HIV 64
Valutazione di parametri immunologici e virologici in soggetti con infezione da HIV-1 sottoposti a terapia HAART affetti da Leishmaniosi viscerale recidivante 64
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 64
Weight gain: A possible side effect of all antiretrovirals 64
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 64
Archi-Prevaleat project. A national register of color-doppler ultrasonography of the epi-aortic vessels in patients living with HIV 64
PrEP in Italy: The time may be ripe but who’s paying the bill? A nationwide survey on physicians’ attitudes towards using antiretrovirals to prevent HIV infection 63
Totale 9.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022469 39 61 12 5 65 8 72 27 46 11 20 103
2022/20231.035 71 67 14 101 106 171 5 177 245 5 40 33
2023/2024496 28 63 21 32 22 135 5 35 4 22 79 50
2024/20252.656 25 287 110 104 567 334 92 86 236 276 293 246
2025/20266.646 382 380 1.081 530 1.065 1.344 641 159 276 403 229 156
Totale 11.982